Australia’s milk powder manufacturer ProviCo says that demand for specialised nutrition across different life stages has been growing and it is hoping to cater to such demand by utilising its expertise in milk protein fractionation.
The Danish company Lyras A/S has given Australian food and beverage company Beston Global Food Company the exclusive rights to use Lyras’ sustainable technology for production of lactoferrin and similar products in Australia and New Zealand, for a limited...
Milk Specialties Global (MSG), a US manufacturer of nutritional ingredients for the health and wellness, performance nutrition and functional food industries, has acquired the 96,000-square-foot, gluten-free certified Kay’s Processing facility, located...
This week we have conversations with Mike Leonard, Motif’s chief technology officer; Jing Hagert, VP of human nutrition ingredients sales for Milk Specialties Global; and Eugene Wang, co-founder and CEO of Sophie's Bionutrients.
Milk Specialties Global, an international whey and milk protein producer, is entering the lactoferrin market following a multi-million-dollar investment at the company’s Fond Du Lac, Wisconsin, facility.
The global Lactoferrin market size is set to surpass €265 million (315 million USD) by 2027, thanks to its increasingly relevant links to infant nutrition, immune health, the microbiome, and skin health, according to Global Market Insights, Inc (GMI).
Research commissioned by New Zealand company Quantec, and completed by an independent US laboratory, has found its patented milk-derived ingredient IDP (Immune Defense Proteins) is effective against influenza virus species.
Morinaga Milk Industry Co., Ltd. has announced its subsidiary Milei GmbH, which, according to 2019 data from Absolute Reports has the largest share of the global market in terms of production volume of the functional ingredient lactoferrin, will more...
FrieslandCampina Ingredients is set to increase its lactoferrin production capacity in Veghel, the Netherlands, by 60 metric tonnes (mt) in 2022 to enable strategic growth in its Early Life Nutrition and Adult Nutrition segments.
Synthetic biology specialist Conagen says it has come up with a cost effective way to produce lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk, a potential game changer in the infant formula market.
Researchers from the Agency for Science, Technology and Research (A*STAR) Singapore have developed a new encapsulation technology that boosts the bioavailability of lactoferrin, a naturally occurring protein in human breast milk.